Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

KYTX

Kyverna Therapeutics, Inc.

CIK 0001994702 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$8.42
↑ 0.29 (3.57%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Options; Risks: Fundamentals

Key stats

Market Cap
$520.72M
P/E Ratio
-3.41
EPS
-3.64
Dividend Yield
Not covered
52W Position
50%
Beta
2.55

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
3.15
P/S
Not covered
EV/Revenue
Not covered
ROE
-92.2%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 50%
$3.27$13.67

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
-$161.31M
Total Assets
$293.83M
Free Cash Flow
-$153.72M

Recent news